Eshelman Fredric N

Executive Chairman, Director

Avg. Two Year Performance

(23%) Avg. Purchase Return    (11%) Compound
No Sale Track Record

Holdings: 2.08M shares

Last Three Months: 30-Dec-23 -- 29-Mar-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

30-Mar-22 -- 29-Mar-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions